Psychological migraine treatment gives sufferers a confidence boostMigraine study in GlasgowMigraine Heroes winners announced- Migraine Action launches new migraine in the workplace information packRelaxation podcast to help manage migraineMigraine Action on Able Radio
- First genetic link to common migraine found20% off an initial consultation at the Peak House PracticeFREE Bowen Technique sessions in Kent
- Migraine linked to heart diseaseOverweight teens are more likely to have chronic headaches or migrainesThe National Launch Meeting for BOTOX® in chronic migraine for healthcare professionals
- Polaroid sunglasses prize drawEducation day in Glasgow for young migraineurs and adult migraineurs - 11th SeptemberNew medication to prevent menstrually related migraine
- YorkTest prize draw winnerWanted - do you suffer from chronic migraine?BOTOX® receives licence in UK as preventative treatment in chronic migraine
- Migraine prophylaxis phase IIb clinical study failsVitamin D Low in patients with headache and migraineMigraine Action receives Communiqué award for Best Patient Association
- Have you got back issues of Migraine Action newsletters?Prescribing trends for severe headache and migraine signal inappropriate medication useMigraineurs who experienced childhood abuse have greater risk of cardiovascular disease
- Have you shared your views in the 2010 members surveyNew research helps explain why sleep deprivation triggers migrainesSociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
- Stigma of migraine is significant; worse for those with chronic migraine
New medication for adults who have headache for more than 15 days
A clinical study is currently underway evaluating an investigational medication for the treatment of headaches in adults with migraine, who have headaches on 15 or more days every month.
The Study
Study participation lasts for approximately 15 months. You will be required to make a brief telephone call every day to answer questions about your headaches and the medications you take to treat the headaches.
If you qualify for the study, you will receive:
- A total of 5 study treatments
- Study-related physical examinations and blood tests at no cost to you.
- Compensation for your travel to the study site.
For more information about this clinical study please contact either:
Dr F Ahmed
Hull Royal Infirmary-tel (secretary) 01482 675825
Prof P J Goadsby
The National Hospital, London
Email: headache_studies@ion.ucl.ac.uk or tel (registrar) 07963 958319
Dr G Elrington
The Royal London Hospital, Whitechapel- tel (secretary) 020 7377 7359
Dr S Weatherby
Derriford Hospital, Plymouth
Email: plh-tr.headache@nhs.net
Dr B Davies
North Midlands Headache Clinic, Stoke -on-Trent
Tel (nurse) 01782 555068 or (secretary) 01782 554689